OtherArticle
Physiologic Targets and Modes of Action for CBL0137, a Lead for Human African Trypanosomiasis Drug Development
Carlos E Sanz-Rodriguez, Benjamin Hoffman, Paul J Guyett, Andrei Purmal, Baljinder Singh, Michael Pollastri and Kojo Mensa-Wilmot
Molecular Pharmacology May 23, 2022, MOLPHARM-AR-2021-000430; DOI: https://doi.org/10.1124/molpharm.121.000430
Carlos E Sanz-Rodriguez
1Cellular Biology, University of Georgia, United States
Benjamin Hoffman
1Cellular Biology, University of Georgia, United States
Paul J Guyett
1Cellular Biology, University of Georgia, United States
Andrei Purmal
2Buffalo BioLabs, United States
Baljinder Singh
3Chemical Biology and Chemistry, Northeastern University, United States
Michael Pollastri
3Chemical Biology and Chemistry, Northeastern University, United States
Kojo Mensa-Wilmot
4Molecular and Cellular Biology, Kennesaw State University, United States
Jump to comment:
No eLetters have been published for this article.
In this issue
OtherArticle
Polypharmacology of CBL0137 in the African Trypanosome
Carlos E Sanz-Rodriguez, Benjamin Hoffman, Paul J Guyett, Andrei Purmal, Baljinder Singh, Michael Pollastri and Kojo Mensa-Wilmot
Molecular Pharmacology May 23, 2022, MOLPHARM-AR-2021-000430; DOI: https://doi.org/10.1124/molpharm.121.000430
OtherArticle
Polypharmacology of CBL0137 in the African Trypanosome
Carlos E Sanz-Rodriguez, Benjamin Hoffman, Paul J Guyett, Andrei Purmal, Baljinder Singh, Michael Pollastri and Kojo Mensa-Wilmot
Molecular Pharmacology May 23, 2022, MOLPHARM-AR-2021-000430; DOI: https://doi.org/10.1124/molpharm.121.000430
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement